
Mid Europa increases Walmark stake to 100%
CEE-focused GP Mid Europa Partners has increased its 50% stake in Czech dietary supplements manufacturer Walmark to 100%, acquiring the shares from the company’s founding family.
The deal saw Mid Europa gain full control of the company, having first bought a 50% stake from the Walach family in 2012 via its 2007-vintage €1.5bn Mid Europa Partners III fund. The exit marks an end to the Walach family's 25 years at the reins of Walmark.
Mid Europa's buyout follows its support of two bolt-on acquisitions for Walmark in 2015: Polish maker of natural respiratory ailments products for children Pneumolan was acquired in June, while Czech bottled probiotics producer Valosun was bolted on in October.
Company
Walmark was founded in 1990 as an export business focused on the information technology trade and household utensils.
The company began trading pharmaceuticals in 1993 before fully focusing on the sector in 2001. Today, Walmark manufactures dietary supplements in a purpose-built production plant in Třinec.
People
Mid Europa's Robert Chmelar, Viktoria Habanova and Tomas Vrba led the deal for the GP. Jorge Manuel is the CEO of Walmark.
Advisers
Equity – White & Case (Legal).
Vendor – Allen & Overy (Legal); Corpin (Corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater